Last reviewed · How we verify
NCT04745325
Randomized Trial of a Smartphone App Designed to Reduce Unhealthy Alcohol Consumption
NA trial testing SMAART Canada smartphone app in Alcohol Consumption in 761 participants. Completed in 30 April 2023.
26 October 2022
Quick facts
| Lead sponsor | Centre for Addiction and Mental Health |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 761 |
| Start date | 27 May 2021 |
| Primary completion | 26 October 2022 |
| Estimated completion | 30 April 2023 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- SMAART Canada smartphone app
Conditions studied
- Alcohol Consumption — all drugs for Alcohol Consumption →
Sponsor
Centre for Addiction and Mental Health — full company profile →
Who can join
18 and older, any sex, with Alcohol Consumption. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Smartphone apps targeting alcohol consumption are increasingly employed as a means to help people reduce their alcohol consumption. Recognizing this potential, there has been an explosion of app development for unhealthy alcohol use, as well as other health-related behaviours. This study will recruit people who consume alcohol in an unhealthy manner. Participants will be assigned by chance to one of two groups and will be contacted 6 months after consenting to the study to assess changes in their drinking. In addition, this study will help us understand which components of the smartphone app are important to use in order to promote reductions in alcohol consumption. An app with proven efficacy, made widely available and free-of-charge to Canadians, will provide a much needed option to help those in need to reduce their alcohol use.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Randomized controlled trial of a smartphone app designed to reduce unhealthy alcohol consumption.
Cunningham JA, Godinho A, Schell C, Studer J, et al · · 2024 · cited 7× · PMID 38812955 · DOI 10.1016/j.invent.2024.100747
Verify or expand the search:
- PubMed search for NCT04745325
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alcohol Consumption
Currently open trials in the same condition.
- NCT07118618 — Probenecid Administration for Alcohol Craving and Consumption · Phase 2 · recruiting
- NCT06962592 — Mentor Moms+ Study · NA · recruiting
- NCT06617702 — Accountability Support Through Peer-Inspired Relationships and Engagement (ASPIRE) Trial · NA · recruiting
- NCT06856161 — A Novel Blood Test as a Biomarker in Mental Health · recruiting
- NCT06770556 — Transcranial Magnetic Stimulation (TMS) Effects Using Magnetoencephalography (MEG) Study · NA · recruiting
Other Centre for Addiction and Mental Health trials
Trials by the same sponsor.
- NCT07211438 — Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression · Phase 2 · not yet recruiting
- NCT07146633 — Efficacy of an EMDR App for PTSD and SUD · NA · recruiting
- NCT07228923 — Development and Evaluation of a Theory and Evidence-based Intervention to Reduce Hazardous Alcohol Consumption Among Tre · NA · not yet recruiting
- NCT07105449 — THC Titration of High-Potency Cannabis Concentrates · NA · not yet recruiting
- NCT06928935 — Digital Dialectical Behavioural Therapy (d-DBT) for Youth at Clinical High Risk (CHR) for Psychosis · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04745325 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre for Addiction and Mental Health
- Last refreshed: 7 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04745325.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing